Cargando…
Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters
Rift Valley fever virus (RVFV) is a mosquito-borne pathogen endemic to sub-Saharan Africa and the Arabian Peninsula. There are no approved antiviral therapies or vaccines available to treat or prevent severe disease associated with RVFV infection in humans. The adenosine analog, galidesivir (BCX4430...
Autores principales: | Westover, Jonna B., Mathis, Amanda, Taylor, Ray, Wandersee, Luci, Bailey, Kevin W., Sefing, Eric J., Hickerson, Brady T., Jung, Kie-Hoon, Sheridan, William P., Gowen, Brian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035881/ https://www.ncbi.nlm.nih.gov/pubmed/29864447 http://dx.doi.org/10.1016/j.antiviral.2018.05.013 |
Ejemplares similares
-
Rift Valley Fever Virus Infection in Golden Syrian Hamsters
por: Scharton, Dionna, et al.
Publicado: (2015) -
MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters
por: Gowen, Brian B., et al.
Publicado: (2015) -
Pathogenesis of Rift Valley Fever Virus Aerosol Infection in STAT2 Knockout Hamsters
por: Hickerson, Brady T., et al.
Publicado: (2018) -
Activity of Galidesivir in a Hamster Model of SARS-CoV-2
por: Taylor, Ray, et al.
Publicado: (2021) -
Generation of transgenic golden Syrian hamsters
por: Gao, Mingming, et al.
Publicado: (2014)